Severe Vasculitis Yields to Rituximab (CME/CE)

(MedPage Today) — The B-cell depleting agent rituximab (Rituxan) effectively alleviates serious manifestations of cryoglobulinemic vasculitis, two groups of researchers found.

Post a Comment

Comments are closed.